Plain-English translation of NCT05205954 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
HepHospital is a pilot study testing a new way to care for people with advanced liver disease (cirrhosis). Instead of staying in a hospital, patients receive the same level of medical care—doctor visits, monitoring, and treatments—at home. The study wants to see if this approach is safe, effective, and helpful for people managing serious liver conditions.
People with advanced liver disease often need frequent hospital visits or stays for complications like fluid buildup or confusion. This trial exists to explore whether receiving this same quality care at home might be safer, more comfortable, and more practical for patients and their families.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would receive medical care for your liver disease at home instead of in a hospital. This means doctors and nurses would visit your home to check on you, manage your medications, and monitor your condition—similar to what would happen in a hospital, but in the comfort of your own space. The study will track how you do over time to see if home-based care works well for people with advanced liver disease.
AI-generated summary from trial data · Aug 13, 2026 · Not medical advice
United States